TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Island Pharmaceuticals Ltd ( (AU:ILA) ) has shared an announcement.
Island Pharmaceuticals Limited has announced its Annual General Meeting (AGM) scheduled for October 9, 2025, in Sydney, Australia. Shareholders are encouraged to attend in person as there will be no virtual access. The company is urging shareholders to submit proxy forms and questions in advance to facilitate a well-prepared meeting. This AGM is significant for stakeholders as it provides an opportunity to discuss the company’s progress, particularly regarding its lead asset, ISLA-101, and its potential impact on the market for antiviral therapeutics.
More about Island Pharmaceuticals Ltd
Island Pharmaceuticals Limited is a clinical-stage drug repurposing company focused on developing antiviral therapeutics for infectious diseases. Its primary product, ISLA-101, is being repurposed for the prevention and treatment of dengue fever and other mosquito-borne diseases. The company aims to address unmet medical needs in this area and may obtain a Priority Review Voucher from the FDA, which could expedite the approval process for future drugs.
Average Trading Volume: 661,618
Technical Sentiment Signal: Buy
Current Market Cap: A$50.45M
For an in-depth examination of ILA stock, go to TipRanks’ Overview page.